USPTO serial 85181158
SELEXON
Reviewed by CopyMark Law Group
Reg. 4398400Status 710
- Filing date
- Status date
- Registration date
- Sep 10, 2013
- Examiner
- HERMAN, RUSS
- Law office
- TMEG LAW OFFICE 101
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SELEXON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Anyang-si, Gyeonggi-do, KR
Gyunggi, KR
Gyunggi, KR
Gyunggi, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Smith
Michael T. Smith Birch, Stewart, Kolasch & Birch, LLP8110 Gatehouse Road, Suite 100 EastFalls Church, VA 22042UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; [ Chemical preparations for the diagnosis of pregnancy; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; Reagents and media for medical and veterinary diagnostic purposes; ] Chemical preparations, biochemical preparations, biological preparations and chemical reagents, all for medical or veterinary use in connection with the detection and identification of contaminants, biological agents, genetic material, infectious agents, microorganisms, pathogens and pollutants, in urine, blood, saliva and excrement; [ Chemical, biochemical, and biological preparations and chemical reagents for diagnostic use dealing with industrial testing, forensic testing, microbial testing and quality assurance testing of pollutants and contaminants in connection with environmental monitoring, food safety and security screening, all for medical or for veterinary purposes; ] Chemical, biochemical or biological preparations and chemical reagents in kit form for use in connection with in vitro and in vivo assays for medical or veterinary purposes; Chemical, biochemical or biological preparations and chemical reagents in kit form for use in connection with diagnostic tests for the detection of a wide variety of infectious diseases, cancers, cardiovascular disorders, genetic material, bio-threat agents, animal diseases, food pathogens, environmental contaminants, mycroplasma, and genetically modified organisms in humans and animals, for medical or veterinary purposes [ ; Chemical, biochemical or biological preparations and chemical reagents in strip form for use in connection with diagnostic tests for the detection of a wide variety of infectious diseases, cancers, cardiovascular disorders, genetic material, bio-threat agents, animal diseases, food pathogens, environmental contaminants, mycroplasma, and genetically modified organisms in humans and animals, for medical or veterinary purposes; Chemical, biochemical or biological preparations and chemical reagents in cassette form for use in connection with diagnostic tests for the detection of a wide variety of infectious diseases, cancers, cardiovascular disorders, genetic material, bio-threat agents, animal diseases, food pathogens, environmental contaminants, mycroplasma, and genetically modified organisms in humans and animals, for medical or veterinary purposes; Chemical, biochemical or biological preparations and chemical reagents in disc form for use in connection with diagnostic tests for the detection of a wide variety of infectious diseases, cancers, cardiovascular disorders, genetic material, bio-threat agents, animal diseases, food pathogens, environmental contaminants, mycroplasma, and genetically modified organisms in humans and animals, for medical or veterinary purposes ] | SECTION 8 - CANCELLED | — |
| 010 | [ Flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometers, hematology analyzers, sample preparation device, and related data management software sold as a unit; ] Blood testing apparatus; Apparatus for blood analysis; Apparatus for taking blood samples; Devices for measuring blood sugar; Medical apparatus and instruments for monitoring oxymetory, gas analysis, vital signs, blood properties and respiratory events; Devices for measuring glycated hemoglobin levels for medical diagnostic use; devices for measuring cholesterol levels for medical diagnostic use; Devices for measuring liver disease stages for medical diagnostic use; Devices for measuring cardiovascular disease stages for medical diagnostic use; Devices for measuring thyroid disease stages for medical diagnostic use; Devices for measuring infectious disease stages for medical diagnostic use; Diagnostic apparatus for the detection of cancer; Medical diagnostic instruments for the analysis of body fluids; Medical instrument for cardiovascular diagnostics; Medical apparatus and instruments for immunodiagnostics; medical apparatus and instruments for genetic diagnostics; Medical and veterinary apparatus and instruments for use in detection and diagnosis of a wide variety of infectious diseases, cancers, genetic material, bio-threat agents, animal diseases, food pathogens, environmental contaminants, mycroplasma, and genetically modified organisms in humans and animals [ ; Medical and veterinary diagnostic testing apparatus for monitoring chemical, biochemical and biological reactions to a wide variety of infectious diseases, cancers, genetic material, bio-threat agents, animal diseases, food pathogens, environmental contaminants, mycroplasma, and genetically modified organisms in humans and animals; Medical and veterinary devices for the preparation, screening and analysis of medical blood samples and blood specimens; Medical, and veterinary apparatus for analyzing pathogens in the blood; Medical and veterinary diagnostic testing equipment for clinical and veterinary diagnosis of a wide variety of infectious diseases and a wide variety of diseases in animals; Medical apparatus for analysis of saliva for medical diagnostic purposes; Medical apparatus for analysis of urine for medical diagnostic purposes; Medical apparatus for analysis of excrement for medical diagnostic purposes; Medical apparatus for non-invasive blood analysis for medical diagnostic purposes ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OSANG HEALTHCARE CO., LTD.
- Other trademarks owned by Infopia Co., Ltd.
- Other trademarks owned by Infopia Co., Ltd.
- Other trademarks owned by Infopia Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named SELEXON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 22, 2024 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Sep 10, 2022 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 17, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 17, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 17, 2020 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 17, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 17, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 8, 2020 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jun 8, 2020 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 26, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 26, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 26, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 26, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 26, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 23, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 23, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 23, 2019 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jul 18, 2019 | PR23 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 | — |
| Jul 18, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 12, 2019 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 10, 2018 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 19, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 28, 2017 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 6, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 10, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 25, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 25, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 5, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 22, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 20, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 20, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 20, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2013 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 13, 2012 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 13, 2012 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 13, 2012 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 13, 2012 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 18, 2012 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 18, 2012 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 18, 2012 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 16, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 16, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 16, 2012 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 17, 2011 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Oct 17, 2011 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Oct 17, 2011 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Mar 31, 2011 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 31, 2011 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 31, 2011 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 25, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 25, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 22, 2011 | ALIE | ASSIGNED TO LIE | — |
| Mar 10, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2011 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2011 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 23, 2010 | NWAP | NEW APPLICATION ENTERED | — |